Home/Filings/4/0001415889-24-020002
4//SEC Filing

Harler Mary Beth 4

Accession 0001415889-24-020002

CIK 0001496323other

Filed

Jul 22, 8:00 PM ET

Accepted

Jul 23, 8:38 PM ET

Size

9.5 KB

Accession

0001415889-24-020002

Insider Transaction Report

Form 4
Period: 2024-07-19
Harler Mary Beth
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2024-07-19+54,999140,226 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2024-07-19200,0000 total
    Exercise: $61.45Exp: 2031-10-11Common Stock (200,000 underlying)
  • Award

    Common Stock

    2024-07-19+25,001165,227 total
Footnotes (3)
  • [F1]These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on July 19, 2025 and one-eighth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
  • [F2]Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 200,000 shares of the Issuer's Common Stock and in exchange issued RSU grants of 54,999 shares and 25,001 shares.
  • [F3]These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on January 19, 2026 and one-twelfth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.

Issuer

IGM Biosciences, Inc.

CIK 0001496323

Entity typeother

Related Parties

1
  • filerCIK 0002018699

Filing Metadata

Form type
4
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 8:38 PM ET
Size
9.5 KB